Article content material
VANCOUVER, British Columbia, June 06, 2023 (GLOBE NEWSWIRE) — Xenon Prescription drugs Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical firm, at this time introduced that the corporate will current on the Goldman Sachs forty fourth Annual World Healthcare Convention in Dana Level, CA.
| Firm Fireplace Chat Presentation Particulars: | |
| Date: | Monday, June 12, 2023 |
| Time: | 10:00 am Pacific Time (1:00 pm Japanese Time) |
| Webcast: | Register here |
| Presenters: | Ian Mortimer, President and CEO Sherry Aulin, CFO |
Article content material
A reside webcast of the corporate presentation shall be obtainable on the “Investors” part of Xenon’s web site and posted for replay following the occasion. The above listed dates and occasions are topic to vary.
About Xenon Prescription drugs Inc.
Xenon Prescription drugs (NASDAQ:XENE) is a medical stage biopharmaceutical firm dedicated to creating revolutionary therapeutics to enhance the lives of sufferers with neurological problems. We’re advancing a novel product pipeline of neurology therapies to handle areas of excessive unmet medical want, with a give attention to epilepsy. For extra info, please go to www.xenon-pharma.com.
“Xenon” and the Xenon brand are registered logos or logos of Xenon Prescription drugs Inc. in varied jurisdictions. All different logos belong to their respective proprietor.
Investor/Media Contact:
Jodi Regts
Xenon Prescription drugs Inc.
Telephone: 604.484.3353
E mail: investors@xenon-pharma.com
